← Open Payments lookup

MEGAN NUSZ: Open Payments

NPI 1790458826 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$842 in 34 payments from 21 companies in 2025. Trend: 2023 $50 · 2024 $0 · 2025 $842

Food & beverage: $643Education: $200
CompanyPaymentsAmount
ABBVIE INC.5$250
Janssen Biotech, Inc.3$74
Merck Sharp & Dohme LLC4$69
Daiichi Sankyo Inc.3$48
Genentech USA, Inc.2$48
Iovance Biotherapeutics, Inc.2$48
Regeneron Healthcare Solutions, Inc.1$39
TerSera Therapeutics LLC1$31
Astellas Pharma US Inc1$30
SERVIER PHARMACEUTICALS LLC1$23

Products named: VENCLEXTA, KEYTRUDA, Amtagvi, RYBREVANT, LYNOZYFIC, CARVYKTI, Zoladex, Vyloy.

Industry payments across NE — which companies pay providers there.